SANARA MEDTECH INC (SMTI) Stock Price & Overview

NASDAQ:SMTI • US79957L1008

Current stock price

19.73 USD
+0.74 (+3.9%)
Last:

The current stock price of SMTI is 19.73 USD. Today SMTI is up by 3.9%. In the past month the price increased by 14.44%. In the past year, price decreased by -40.01%.

SMTI Key Statistics

52-Week Range16.0465 - 35.85
Current SMTI stock price positioned within its 52-week range.
1-Month Range16.21 - 21.49
Current SMTI stock price positioned within its 1-month range.
Market Cap
180.924M
P/E
N/A
Fwd P/E
29.76
EPS (TTM)
-0.46
Dividend Yield
N/A

SMTI Stock Performance

Today
+3.9%
1 Week
+2.65%
1 Month
+14.44%
3 Months
-10.32%
Longer-term
6 Months -32.66%
1 Year -40.01%
2 Years -33.57%
3 Years -41.17%
5 Years -33.01%
10 Years N/A

SMTI Stock Chart

SANARA MEDTECH INC / SMTI Daily stock chart

SMTI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SMTI. When comparing the yearly performance of all stocks, SMTI is a bad performer in the overall market: 88.39% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SMTI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SMTI. SMTI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SMTI Earnings

On March 24, 2026 SMTI reported an EPS of 0.09 and a revenue of 27.55M. The company missed EPS expectations (-19.79% surprise) and missed revenue expectations (-1.44% surprise).

Next Earnings DateMay 12, 2026
Last Earnings DateMar 24, 2026
PeriodQ4 / 2025
EPS Reported$0.09
Revenue Reported27.546M
EPS Surprise -19.79%
Revenue Surprise -1.44%

SMTI Forecast & Estimates

7 analysts have analysed SMTI and the average price target is 34.68 USD. This implies a price increase of 75.77% is expected in the next year compared to the current price of 19.73.

For the next year, analysts expect an EPS growth of 243.51% and a revenue growth 15.65% for SMTI


Analysts
Analysts82.86
Price Target34.68 (75.77%)
EPS Next Y243.51%
Revenue Next Year15.65%

SMTI Index Membership

SMTI is currently included in the following stock indexes tracked on ChartMill.

SMTI Financial Highlights

Over the last trailing twelve months SMTI reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS increased by 59.47% compared to the year before.


Income Statements
Revenue(TTM)103.14M
Net Income(TTM)-37.56M
Industry RankSector Rank
PM (TTM) N/A
ROA -51.5%
ROE -632.54%
Debt/Equity 7.74
Chartmill High Growth Momentum
EPS Q2Q%150%
Sales Q2Q%4.72%
EPS 1Y (TTM)59.47%
Revenue 1Y (TTM)19.01%

SMTI Ownership

Ownership
Inst Owners21.35%
Shares9.17M
Float3.28M
Ins Owners9.09%
Short Float %7.96%
Short Ratio4.17

SMTI Industry Overview

SMTI operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.

Industry Strength Score

17/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.

Industry Growth Score

32/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.

Relative Performance

Each rank shows how many other sub-industries were outperformed over that timeframe.

1 Month Rank
27%
Outperformed 27% of sub-industries
3 Month Rank
21%
Outperformed 21% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries

Industry Fundamentals & Breadth

Members
34
New Highs
2.9%
New Lows
14.7%
Average ROE
12.6%
Average Profit Margin
7.9%
Average Operating Margin
10.8%
Average P/E
24.7
Average Fwd P/E
21.6
Average Debt/Equity
0.9

About SMTI

Company Profile

SMTI logo image Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Company Info

IPO: 1994-04-07

SANARA MEDTECH INC

1200 Summit Avenue, Suite 414

Fort Worth TEXAS 76102 US

CEO: Ronald T. Nixon

Employees: 108

SMTI Company Website

SMTI Investor Relations

Phone: 18175292300

SANARA MEDTECH INC / SMTI FAQ

What does SMTI do?

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.


What is the stock price of SANARA MEDTECH INC today?

The current stock price of SMTI is 19.73 USD. The price increased by 3.9% in the last trading session.


What is the dividend status of SANARA MEDTECH INC?

SMTI does not pay a dividend.


What is the ChartMill technical and fundamental rating of SMTI stock?

SMTI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is SANARA MEDTECH INC (SMTI) stock traded?

SMTI stock is listed on the Nasdaq exchange.


What is SANARA MEDTECH INC worth?

SANARA MEDTECH INC (SMTI) has a market capitalization of 180.92M USD. This makes SMTI a Micro Cap stock.


Who owns SANARA MEDTECH INC?

You can find the ownership structure of SANARA MEDTECH INC (SMTI) on the Ownership tab.